|
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sphinganine
|
K025078-50ug
|
99% |
474943-05-0 |
50ug
|
¥ 1390.0
|
4~8周 |
|
0 |
科威 |
|
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025077-50ug
|
99% |
474943-04-9 |
50ug
|
¥ 4088.0
|
4~8周 |
|
0 |
科威 |
|
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025077-250ug
|
99% |
474943-04-9 |
250ug
|
¥ 15331.0
|
4~8周 |
|
0 |
科威 |
|
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025077-100ug
|
99% |
474943-04-9 |
100ug
|
¥ 7052.0
|
4~8周 |
|
0 |
科威 |
|
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-100ug
|
99% |
474943-01-6 |
100ug
|
¥ 7052.0
|
4~8周 |
|
0 |
科威 |
|
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-50ug
|
99% |
474943-01-6 |
50ug
|
¥ 4088.0
|
4~8周 |
|
0 |
科威 |
|
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-250ug
|
99% |
474943-01-6 |
250ug
|
¥ 15331.0
|
4~8周 |
|
0 |
科威 |
|
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-ß1-1''-sphingosine
|
K025075-250ug
|
99% |
474942-98-8 |
250ug
|
¥ 15331.0
|
4~8周 |
|
0 |
科威 |
|
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-ß1-1''-sphingosine
|
K025075-100ug
|
99% |
474942-98-8 |
100ug
|
¥ 7052.0
|
4~8周 |
|
0 |
科威 |
|
1,2-Dioleoyl-sn-Glycero-3-Phospho(Ethylene Glycol) (Sodium Salt)
|
K025071-500mg
|
99% |
474923-51-8 |
500mg
|
¥ 11243.0
|
4~8周 |
|
0 |
科威 |
|
1,2-Dioleoyl-sn-Glycero-3-Phospho(Ethylene Glycol) (Sodium Salt)
|
K025071-25mg
|
99% |
474923-51-8 |
25mg
|
¥ 1880.0
|
4~8周 |
|
0 |
科威 |
|
1,2-Dioleoyl-sn-Glycero-3-Phospho(Ethylene Glycol) (Sodium Salt)
|
K025071-100mg
|
99% |
474923-51-8 |
100mg
|
¥ 5110.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanoyl) (sodium salt)
|
K025070-100mg
|
99% |
474923-49-4 |
100mg
|
¥ 5519.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanoyl) (sodium salt)
|
K025070-500mg
|
99% |
474923-49-4 |
500mg
|
¥ 17784.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanoyl) (sodium salt)
|
K025070-25mg
|
99% |
474923-49-4 |
25mg
|
¥ 1676.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanyl) (sodium salt)
|
K025069-500mg
|
99% |
474923-47-2 |
500mg
|
¥ 17988.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanyl) (sodium salt)
|
K025069-25mg
|
99% |
474923-47-2 |
25mg
|
¥ 1880.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanyl) (sodium salt)
|
K025069-100mg
|
99% |
474923-47-2 |
100mg
|
¥ 5723.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(glutaryl) (sodium salt)
|
K025068-100mg
|
99% |
474923-45-0 |
100mg
|
¥ 4906.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(glutaryl) (sodium salt)
|
K025068-500mg
|
99% |
474923-45-0 |
500mg
|
¥ 11039.0
|
4~8周 |
|
0 |
科威 |
|
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(glutaryl) (sodium salt)
|
K025068-25mg
|
99% |
474923-45-0 |
25mg
|
¥ 1676.0
|
4~8周 |
|
0 |
科威 |
|
1,2-二棕榈酰-Sn-甘油-3-磷酸硫醇 (钠盐))
|
K025067-25mg
|
99% |
474923-39-2 |
25mg
|
¥ 1960.0
|
4~8周 |
|
0 |
科威 |
|
1,2-二棕榈酰-Sn-甘油-3-磷酸硫醇 (钠盐))
|
K025067-200mg
|
99% |
474923-39-2 |
200mg
|
¥ 9407.0
|
4~8周 |
|
0 |
科威 |
|
1,2-二棕榈酰-Sn-甘油-3-磷酸硫醇 (钠盐))
|
K025067-100mg
|
99% |
474923-39-2 |
100mg
|
¥ 5375.0
|
4~8周 |
|
0 |
科威 |